Sam’s role includes managing and coordinating successful drug submissions to the Patented Medicines Prices Review Board (PMPRB), the Canadian Agency for Drugs and Technologies in Health (CADTH), Institut national d’excellence en santé et en services sociaux (INESSS), Federal/Provincial/Territorial (F/P/T) public drug plans and private drug plans.

Sam maintains a strong working relationship with drug plan managers, ensuring access to the most up-to-date and accurate information with regards to wide-ranging drug plan policies and regulations. Sam also provides assistance on pricing and reimbursement assessments, as well as other market access consulting projects and reports.